Samuel Wang, Honorary President of the Taiwan Generics Pharmaceutical Association (TGPA) and President of the local distributor Weal-Chance Trading, provides insights into the recent international achievements of TGPA and the main strengths of Taiwan’s generics industry on the global stage, while he explains how bolstering the country’s historical strengths in new formulations and drug delivery systems could also help Taiwan to eventually fulfill its ambitions in terms of new drug development.
TGPA notably holds the ambition to promote and foster the development of Taiwan’s generics industry on the international stage. How have you been progressing in this regard over the past years?
"Taiwan undoubtedly holds a very experienced generics industry that has already reached international standards."
